Literature DB >> 15752725

Measurement and characterization of C-3 epimerization activity toward vitamin D3.

Maya Kamao1, Susumi Hatakeyama, Toshiyuki Sakaki, Natsumi Sawada, Kuniyo Inouye, Noboru Kubodera, G Satyanarayana Reddy, Toshio Okano.   

Abstract

Recently, epimerization of the hydroxyl group at C-3 has been identified as a unique metabolic pathway of vitamin D compounds. We measured C-3 epimerization activity in subcellular fractions prepared from cultured cells and investigated the basic properties of the enzyme responsible for the epimerization. C-3 epimerization activity was detected using a NADPH-generating system containing glucose-6-phosphate, NADP, glucose-6-phosphate dehydrogenase, and Mg(2+). The highest level of activity was observed in a microsomal fraction prepared from rat osteoblastic UMR-106 cells but activity was also observed in microsomal fractions prepared from MG-63, Caco-2, Hep G2, and HUH-7 cells. In terms of maximum velocity (V(max)) and the Michaelis constant (K(m)), 25-hydroxyvitamin D(3) [25(OH)D(3)] exhibited the highest specificity for the epimerization at C-3 among 1alpha,25-dihydroxyvitamin D(3) [1alpha,25(OH)(2)D(3)], 25(OH)D(3), 24,25-dihydroxyvitamin D(3) [24,25(OH)(2)D(3)], and 22-oxacalcitriol (OCT). The epimerization activity was not inhibited by various cytochrome P450 inhibitors and antiserum against NADPH cytochrome P450 reductase. Neither CYP24, CYP27A1, CYP27B1 nor 3(alpha-->beta)hydroxysteroid epimerase (HSE) catalyzed the epimerization in vitro. Based on these results, the enzyme(s) responsible for the epimerization of vitamin D(3) at C-3 are thought to be located in microsomes and different from cytochrome P450 and HSE.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752725     DOI: 10.1016/j.abb.2005.01.017

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Case report: Three patients with substantial serum levels of 3-epi-25(OH)D including one with 3-epi-25(OH)D2 while on high-dose ergocalciferol.

Authors:  Donald Wiebe; Neil Binkley
Journal:  J Clin Endocrinol Metab       Date:  2014-01-29       Impact factor: 5.958

Review 2.  The serum vitamin D metabolome: What we know and what is still to discover.

Authors:  Robert C Tuckey; Chloe Y S Cheng; Andrzej T Slominski
Journal:  J Steroid Biochem Mol Biol       Date:  2018-09-08       Impact factor: 4.292

Review 3.  Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein - A position paper from the IFCC Committee on bone metabolism.

Authors:  Konstantinos Makris; Harjit P Bhattoa; Etienne Cavalier; Karen Phinney; Christopher T Sempos; Candice Z Ulmer; Samuel D Vasikaran; Hubert Vesper; Annemieke C Heijboer
Journal:  Clin Chim Acta       Date:  2021-03-10       Impact factor: 6.314

Review 4.  Vitamin D Metabolites: Analytical Challenges and Clinical Relevance.

Authors:  N Alonso; S Zelzer; G Eibinger; M Herrmann
Journal:  Calcif Tissue Int       Date:  2022-03-03       Impact factor: 4.000

Review 5.  Epimers of Vitamin D: A Review.

Authors:  Bashar Al-Zohily; Asma Al-Menhali; Salah Gariballa; Afrozul Haq; Iltaf Shah
Journal:  Int J Mol Sci       Date:  2020-01-11       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.